Reliable Data You Can Trust
Reliable Data You Can Trust
A recent report published by Infinium Global Research on genotyping market provides in-depth analysis of segments and sub-segments in the global as well as regional genotyping market. The study also highlights the impact of drivers, restraints, and macro indicators on the global and regional genotyping market over the short term as well as long term. The report is a comprehensive presentation of trends, forecast and dollar values of global genotyping market.
Genotyping is the analysis of an individual's genetic material, such as DNA, to identify specific genetic variations or markers. It involves studying regions of the genome to detect variations like SNPs, insertions, deletions, or copy number variations. Genotyping helps determine an individual's genetic makeup, enabling insights into disease predisposition, medication response, ancestry, and trait associations. Techniques such as PCR, DNA sequencing, and microarray analysis are commonly used. Genotyping has applications in medicine, genetics research, personalized medicine, agriculture, forensics, and population genetics. It contributes to understanding disease genetics, developing targeted therapies, improving crop yield, solving crimes, and studying human populations.
The rising penetration of genetic diseases such as cancer, diabetes, and tuberculosis drives the genotyping market. The rising penetration of genetic diseases, such as cancer, diabetes, and tuberculosis, has significantly contributed to the growth of the genotyping market. Genotyping plays a crucial role in understanding the genetic factors and variations associated with these diseases, leading to improved disease management, personalized treatments, and targeted interventions. In the case of cancer, genotyping helps identify specific genetic mutations and markers that are linked to different types of cancer. In the case of tuberculosis, genotyping techniques are employed to analyze the genetic variations of the Mycobacterium tuberculosis bacterium. Additionally, the demand for genotyping in the pharmaceutical industry is fueled by the need for more personalized and effective treatments, driving the growth of the genotyping market thus it is necessary for manufacturers to conduct research and development in the pharmaceutical sector. However, strict rules and regulations as well as unfavorable reimbursement practices are limiting the market growth of genotyping. Although, the deployment of genotyping technological advancement boosts the market of genotyping in the future. Genotyping resolution dramatically increased with the development of DNA microarray technology.
The global genotyping market is segmented into the Asia Pacific, North America, Europe, the Middle East & Africa, and South America. Among the regions, North America is anticipated to dominate the genotyping market during the forecast period. Factors contributing to its dominance include the presence of advanced healthcare infrastructure, robust research and development activities, increased adoption of personalized medicine, and significant investments in genomics research and technology within the region. The Asia Pacific region is expected to be the fastest-growing region during the forecast period. Asia-Pacific is the fastest growing region owing to the rapid increase in population and rising prevalence of genetic diseases due to which genotyping market is growing.
| Report Coverage | Details |
|---|---|
| Market Size in 2022 | USD 13.3 Billion |
| Market Size by 2030 | USD 38.7 Billion |
| Growth Rate from 2023 to 2030 | CAGR of 12.5% |
| Largest Market | North America |
| No. of Pages | 300 |
| Market Drivers |
|
| Market Segmentation | By Product, By Technology, By Application, and By End-use |
| Regional Scope | North America, Europe, Asia Pacific, and RoW |
The report on global genotyping market covers segments such as product, technology, application, and end-use. On the basis of product, the sub-markets include instruments, reagents & kits, bioinformatics, and software and services. On the basis of technology, the sub-markets include PCR, capillary electrophoresis, microarrays, MALDI-TOF, sequencing, mass spectrometry, and others. On the basis of application, the sub-markets include pharmacogenomics, diagnostics, personalized medicine, agricultural biotechnology, animal genetic, and others. On the basis of end-use, the sub-markets include pharmaceutical and biopharmaceutical companies, diagnostics and research laboratories, academic institutes, and others.
The report provides profiles of the companies in the market such as Illumina, Inc., Thermo Fisher Scientific Inc., QIAGEN, F. Hoffmann-La Roche Ltd, Fluidigm (is now Standard BioTools), Danaher, Agilent Technologies, Inc., Eurofins Scientific, GE HealthCare, and BGI Group.
The report provides deep insights into demand forecasts, market trends, and micro and macro indicators. In addition, this report provides insights into the factors that are driving and restraining the growth in this market. Moreover, The IGR-Growth Matrix analysis given in the report brings an insight into the investment areas that existing or new market players can consider. The report provides insights into the market using analytical tools such as Porter's five forces analysis and DRO analysis of the genotyping market. Moreover, the study highlights current market trends and provides forecasts from 2023-2030. We also have highlighted future trends in the market that will affect the demand during the forecast period. Moreover, the competitive analysis given in each regional market brings an insight into the market share of the leading players.
